Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The drug combination significantly reduced epileptic drop attacks in patients.

Tazarotene gel may be more effective for acne than adapalene gel.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Letrozole reduces seizures but not brain damage in mice.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

5 mg/mL of triamcinolone acetonide is most effective for hair regrowth with fewer side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.